ABSTRACT
OBJECTIVES: Characterise inhalational exposures during deployment to Afghanistan and Southwest Asia and associations with postdeployment respiratory symptoms. METHODS: Participants (n=1960) in this cross-sectional study of US Veterans (Veterans Affairs Cooperative Study 'Service and Health Among Deployed Veterans') completed an interviewer-administered questionnaire regarding 32 deployment exposures, grouped a priori into six categories: burn pit smoke; other combustion sources; engine exhaust; mechanical and desert dusts; toxicants; and military job-related vapours gas, dusts or fumes (VGDF). Responses were scored ordinally (0, 1, 2) according to exposure frequency. Factor analysis supported item reduction and category consolidation yielding 28 exposure items in 5 categories. Generalised linear models with a logit link tested associations with symptoms (by respiratory health questionnaire) adjusting for other covariates. OR were scaled per 20-point score increment (normalised maximum=100). RESULTS: The cohort mean age was 40.7 years with a median deployment duration of 11.7 months. Heavy exposures to multiple inhalational exposures were commonly reported, including burn pit smoke (72.7%) and VGDF (72.0%). The prevalence of dyspnoea, chronic bronchitis and wheeze in the past 12 months was 7.3%, 8.2% and 15.6%, respectively. Burn pit smoke exposure was associated with dyspnoea (OR 1.22; 95% CI 1.06 to 1.47) and chronic bronchitis (OR 1.22; 95% CI 1.13 to 1.44). Exposure to VGDF was associated with dyspnoea (OR 1.29; 95% CI 1.14 to 1.58) and wheeze (OR 1.18; 95% CI 1.02 to 1.35). CONCLUSION: Exposures to burn pit smoke and military occupational VGDF during deployment were associated with an increased odds of chronic respiratory symptoms among US Veterans.
Subject(s)
Bronchitis, Chronic , Occupational Exposure , Veterans , Humans , Adult , Bronchitis, Chronic/epidemiology , Bronchitis, Chronic/etiology , Occupational Exposure/adverse effects , Cross-Sectional Studies , Environmental Exposure/adverse effects , Smoke , Dyspnea/epidemiology , Dyspnea/etiology , Gases/analysis , DustABSTRACT
BACKGROUND: Knowledge about the consequences of electronic cigarette (EC) use on respiratory health is still limited. We aimed to assess whether EC use is associated with the occurrence of asthma symptoms and chronic bronchitis among the French adult population, with a specific focus on never combustible cigarettes (CC) smokers. We further investigated whether the association differed in men and women. METHODS: Constances is a population-based cohort of adults aged 18-69 years at inception. We analyzed baseline data collected in 136,276 participants recruited in 2015-2019. Associations of current and former EC use with respiratory symptoms (asthma symptom score and chronic bronchitis) were assessed, controlling for CC smoking, cannabis use, demographics, education and body mass index (BMI). RESULTS: Increased frequencies of respiratory symptoms were observed in both current and former EC users (for the asthma symptom score, adjusted mean score ratio (aMSR): 1.34 [95 % confidence interval: 1.28-1.41] and 1.39 [1.33-1.45], respectively; for chronic bronchitis, adjusted prevalence ratio (aPR): 1.27 [1.19-1.36] and 1.40 [1.32-1.48], respectively). Among never CC smokers, ever EC use was associated with an increased asthma symptom score in both men and women (aMSR = 1.44 [1.09-1.90] and 1.36 [1.01-1.83], respectively), and with a higher prevalence of chronic bronchitis only in women (aPR = 1.97 [1.27-3.05]). CONCLUSION: EC use is associated with symptoms of asthma and chronic bronchitis, independently of CC smoking and cannabis use. The fact that these associations are observed among individuals who have never smoked tobacco adds further evidence of the deleterious effects of EC on respiratory health.
Subject(s)
Asthma , Bronchitis, Chronic , Electronic Nicotine Delivery Systems , Vaping , Adult , Male , Humans , Female , Vaping/adverse effects , Vaping/epidemiology , Bronchitis, Chronic/epidemiology , Bronchitis, Chronic/etiology , Smoking/adverse effects , Smoking/epidemiology , Asthma/epidemiology , Asthma/etiology , Asthma/diagnosisABSTRACT
BACKGROUND: Ambient air pollution increases the risk of respiratory mortality and morbidity, but evidence concerning effects of air pollution on chronic bronchitis (CB) is scarce. This study aimed to evaluate the associations of a set of air pollutants with the burden of CB, and to explore potential modifiers on the associations. METHODS: In 2020, a total of 6,556,440 adults living in the Northwestern region of China were recruited. The Space-Time Extra-Trees model was employed to assess the annual average concentrations of six air pollutants for the three years (2017-2019) before 2020 , and subsequently allocated to the participants based on the latitude and longitude of their home addresses. We investigated the associations between the levels of various air pollutants and the odds of CB using generalized linear mixed models, and conducted multiple sensitivity analyses and subgroup analyses. RESULTS: The odds of CB displays an approximately linear association with particulate matter with aerodynamic diameter ≤2.5 µm (PM2.5), particulate matter with aerodynamic diameter ≤10 µm (PM10), while it shows a non-linear relationship with gaseous pollutants. In the adjusted model, the odds ratios and 95% confidence intervals for CB per 10 µg/m3 increase in PM2.5, PM10, and sulfur dioxide (SO2) were 1.297 (1.262-1.332), 1.072 (1.064-1.080), and 2.587 (2.186-3.063), respectively. Furthermore, several additional sensitivity analyses demonstrated the stability of these associations. Subgroup analyses found that the aforementioned associations were greater among participants aged below 50 years old and those who smoked and had no leisure time exercise. CONCLUSION: Long-term exposure to ambient air pollutants may increase the odds of CB, especially among younger people and those with unhealthy lifestyles.
Subject(s)
Air Pollutants , Air Pollution , Bronchitis, Chronic , Environmental Pollutants , Adult , Humans , Aged , Middle Aged , Bronchitis, Chronic/epidemiology , Bronchitis, Chronic/etiology , Air Pollution/adverse effects , Air Pollution/analysis , Air Pollutants/toxicity , Air Pollutants/analysis , Particulate Matter/toxicity , Particulate Matter/analysis , China/epidemiology , Environmental Pollutants/analysis , Nitrogen Dioxide/analysis , Environmental Exposure/adverse effects , Environmental Exposure/analysisABSTRACT
Background: Chronic obstructive pulmonary disease (COPD) has become one of the most significant chronic diseases in China. According to conventional wisdom, smoking is the pathogenic factor. However, current research indicates that the pathophysiology of COPD may be associated with prior respiratory system events (e.g., childhood hospitalization for pneumonia, chronic bronchitis) and environmental exposure (e.g., dust from workplace, indoor combustion particles). Dyspnea, persistent wheezing, and other respiratory symptoms further point to the need for pulmonary function tests in this population. Reducing the burden of chronic diseases in China requires a thorough understanding of the various factors that influence the occurrence of COPD. Methods: Using a cohort from the natural population, this study used nested case-control analysis. We carried out a number of researches, including questionnaire surveys and pulmonary function testing, in the Northwest and Southeast cohorts of China between 2014 and 2021. After removing any variations in the baseline data between patients and control subjects using propensity score matching analysis, the risk factors were examined using univariate or multivariate regression. Result: It was discovered that prior history of chronic bronchitis, long-term wheezing symptoms, and environmental exposure-including smoking and biofuel combustion-were risk factors for COPD. Dyspnea, symptoms of mobility limitation, organic matter, and a history of hospitalization for pneumonia at an early age were not significant in the clinical model but their incidence in COPD group is higher than that in healthy population. Discussion: COPD screening effectiveness can be increased by looking for individuals with chronic respiratory symptoms. Smokers should give up as soon as they can, and families that have been exposed to biofuels for a long time should convert to clean energy or upgrade their ventilation. Individuals who have previously been diagnosed with emphysema and chronic bronchitis ought to be extra mindful of the prevention or advancement of COPD.
Subject(s)
Bronchitis, Chronic , Pneumonia , Pulmonary Disease, Chronic Obstructive , Humans , Child , Bronchitis, Chronic/etiology , Bronchitis, Chronic/complications , Respiratory Sounds , Case-Control Studies , Pulmonary Disease, Chronic Obstructive/epidemiology , Pulmonary Disease, Chronic Obstructive/etiology , Risk Factors , Dyspnea/etiologyABSTRACT
This study aimed to identify the risk factors associated with chronic bronchitis among patients seeking medical attention for respiratory conditions in Al-Najaf Al-Ashraf city, Iraq. The study employed a case-control design and recruited 134 participants using convenient sampling. Data was collected using a questionnaire consisting of four parts which included demographic characteristics, individual factors, family history, and seasonal, environmental, and nutritional factors. The majority of participants were males aged between 21 and 35 years, with 71.8% of the study group residing in rural areas and 66.3% of the control group living in urban areas. We found that asthma was the most prevalent associated disease among chronic bronchitis patients, with 64.1% reporting it. The risk factors associated with chronic bronchitis were residency, smoking, exposure to secondhand smoke, respiratory sensitivity, dust sensitivity, spring sensitivity, hay fever, asthma, pulmonary obstruction, pneumonia, pertussis, and family history. The study highlights the need for smoking cessation, physical fitness, and healthy eating habits to prevent chronic bronchitis. The findings of this study are important for healthcare professionals in Iraq to design and implement effective prevention and management strategies for chronic bronchitis.
Subject(s)
Asthma , Bronchitis, Chronic , Male , Humans , Adult , Young Adult , Female , Bronchitis, Chronic/etiology , Bronchitis, Chronic/complications , Iraq/epidemiology , Prevalence , Asthma/epidemiology , Asthma/etiology , Risk Factors , Chronic DiseaseABSTRACT
OBJECTIVES: occupational exposure to vapours, gases, dusts and fumes (VGDF) plays an important role in the development and exacerbation of respiratory diseases. The aim of this study is to evaluate the possible association of occupational exposure to airborne pollutants and chronic respiratory diseases. DESIGN: multicase-control study. SETTING AND PARTICIPANTS: cases of chronic respiratory diseases and controls from the Italian multicentric study Gene Environment Interaction in Respiratory Diseases (GEIRD). MAIN OUTCOME MEASURES: the occurrence of rhinitis, asthma, chronic bronchitis/chronic obstructive pulmonary disease (COPD), asthma severity, spirometry data, exhaled nitric oxide (FeNO) were examined in relation to chronic and acute occupational exposures to airborne pollutants using multiple regression models. RESULTS: 2,943 subjects were enrolled in the study. Regularm exposure to VGDF was associated with a higher prevalence of chronic bronchitis/COPD (OR 1.40, 95%CI 0.98-1.99), especially in those also having asthma (OR 1.80, 95%CI 1.14-2.85), a lower prevalence of remittent asthma (OR 0.53, 95%CI 0.29-0.96) and, in those with asthma, an increased activity of the disease (severity score) (OR 1.77, 95%CI 1.20-2.60). No associations were observed between occupational exposure and prevalence of rhinitis, spirometry and FeNO data. Finally, an association was found between acute exposure to airborne pollutants (occupational and non-occupational) and the respiratory diseases investigated, in particular active asthma and asthma associated chronic bronchitis/BPCO. CONCLUSIONS: these data confirm a significant role of occupational exposure to airborne pollutants on respiratory health, underlying the importance of workplace exposure prevention, in particular for more susceptible subjects, as those with respiratory diseases.
Subject(s)
Asthma , Bronchitis, Chronic , Environmental Pollutants , Occupational Diseases , Occupational Exposure , Pulmonary Disease, Chronic Obstructive , Respiration Disorders , Rhinitis , Humans , Bronchitis, Chronic/epidemiology , Bronchitis, Chronic/etiology , Prevalence , Risk Factors , Occupational Diseases/epidemiology , Occupational Diseases/etiology , Italy/epidemiology , Pulmonary Disease, Chronic Obstructive/epidemiology , Pulmonary Disease, Chronic Obstructive/etiology , Asthma/epidemiology , Asthma/etiology , Occupational Exposure/adverse effects , Workplace , GasesABSTRACT
There is increasing evidence that sex hormones may impact the development of obstructive lung disease (OLD). Therefore, we studied the effect of bilateral oophorectomy (oophorectomy) on the development of OLD. Women were identified from the Mayo Clinic Cohort Study of Oophorectomy and Aging-2. Data were collected using the Rochester Epidemiology Project records-linkage system. A total of 1653 women who underwent oophorectomy and 1653 referent women of similar age were assessed for OLD using diagnostic codes and medical record abstraction. Women who underwent oophorectomy had an overall higher risk of all OLD, all chronic obstructive pulmonary disease (COPD), emphysema, and chronic bronchitis but not of all asthma, confirmed asthma, or confirmed COPD. The association with all OLD was stronger in women who were age ≤45 years at oophorectomy, never smokers, non-obese, and in women with benign indications; however, the interactions were not statistically significant. There was an increased risk of all asthma in women age ≤45 years at oophorectomy who took estrogen therapy. Never smokers of all ages had a stronger association of oophorectomy with all asthma and all COPD, whereas smokers had a stronger association of oophorectomy with emphysema and chronic bronchitis. Non-obese women of all ages had a stronger association of oophorectomy with all COPD, emphysema, and chronic bronchitis. The results of this study combined with the increased risk of several chronic diseases reported in previous studies suggest that oophorectomy in premenopausal women should be avoided unless there is clear evidence of a high genetic risk of ovarian cancer.
Subject(s)
Asthma , Bronchitis, Chronic , Emphysema , Pulmonary Disease, Chronic Obstructive , Female , Humans , Middle Aged , Cohort Studies , Bronchitis, Chronic/etiology , Ovariectomy/adverse effects , Pulmonary Disease, Chronic Obstructive/diagnosis , Risk Factors , Asthma/epidemiology , Asthma/etiology , Emphysema/etiologyABSTRACT
Exposures to dust, vapors, or fumes (DVF) are associated with chronic bronchitis (CB) and emphysema. The 2007-2012 National Health and Nutrition Examination Survey data were used to estimate age-standardized prevalence of CB and emphysema among ever-employed adults by exposure status and industry and occupation groups. Age-standardized CB and emphysema prevalence were 2.3% and 1.9%, respectively. Of the estimated 111 million U.S. workers exposed to DVF, 2.7% reported CB and 2.8% reported emphysema. Workers in the "accommodation, food services" industry and "food preparation, serving related" occupations were more likely to report CB and emphysema. Current findings indicate that workplace exposures may be associated with high prevalence of CB and emphysema in certain industry and occupational groups. Early diagnosis and identifying associated workplace exposures are important steps in CB and emphysema prevention efforts.
Subject(s)
Bronchitis, Chronic , Emphysema , Occupational Diseases , Occupational Exposure , Adult , Bronchitis, Chronic/epidemiology , Bronchitis, Chronic/etiology , Dust , Emphysema/epidemiology , Emphysema/etiology , Humans , Nutrition Surveys , Occupational Diseases/diagnosis , Occupational Diseases/epidemiology , Occupational Diseases/etiology , Occupational Exposure/adverse effects , Occupations , PrevalenceABSTRACT
Acute exacerbations of chronic obstructive pulmonary disease (AECOPD) are amongst the most common reasons for hospital admission, and recurrent episodes occur frequently. Comprehensive care management (CCM) strategies have modest effect in preventing re-admissions. The objectives of this study were to examine the utility of optimizing anti-inflammatory therapy guided by sputum cytometry in the post-hospitalization setting, and to assess the feasibility and effectiveness of a clinic combining CCM and sputum-guided therapy. This is an observational study examining patients who received open-label CCM and sputum cytometry-guided pharmacotherapy in a COPD post-discharge clinic. Referral was based on high risk for readmission after hospitalization for AECOPD. The primary outcome was the change in COPD-related healthcare utilization before and after Visit 1, and this was analyzed with a mixed-effects negative binomial model controlling for age, number of follow-up clinic visits, pack years, current smoking and FEV1. Of 138 patients referred to the clinic, 73% attended at least one visit. Mean FEV1 was 42.8 (19.3) % predicted. Of the patients attending clinic, 42.6% produced an adequate sputum sample, and 32.7% had an abnormal sputum. By individual, infectious bronchitis was the most common (25.7%), followed by eosinophilic bronchitis (13.9%). Comparing the 6-months prior to and after the first clinic visit, there was a lower incidence rate ratio after visit 1 for COPD-related healthcare utilization (0.26 (95%CI 0.22,0.33; p < 0.001)). A COPD post-discharge clinic combining sputum-guided treatment and CCM was feasible and associated with a nearly 75% reduction in the incidence of COPD-related healthcare utilization.
Subject(s)
Bronchitis, Chronic , Comprehensive Health Care , Pulmonary Disease, Chronic Obstructive , Aftercare , Aged , Algorithms , Anti-Inflammatory Agents/therapeutic use , Bronchitis, Chronic/etiology , Bronchitis, Chronic/microbiology , Bronchitis, Chronic/pathology , Bronchitis, Chronic/therapy , Disease Progression , Feasibility Studies , Female , Humans , Male , Middle Aged , Patient Discharge , Pulmonary Disease, Chronic Obstructive/complications , Pulmonary Disease, Chronic Obstructive/drug therapy , Pulmonary Disease, Chronic Obstructive/pathology , Pulmonary Disease, Chronic Obstructive/therapy , Retrospective Studies , Sputum/cytology , Treatment OutcomeABSTRACT
OBJECTIVES: To study prevalence of chronic bronchitis (CB) in residential populations and its relationship with mortality in a 50-year follow-up. MATERIAL AND METHODS: In the late 1950's-early 1960's, 7047 men aged 40-59 years were enrolled in 10 European cohorts of the Seven Countries Study (in Finland, the Netherlands, Italy, Serbia and Greece). After baseline examination, follow-up for mortality was extended during 50 years (45 year in the Serbian cohorts). Prevalence of CB, and 50-year mortality from CB and other major causes of death were used as end-points to identify their determinants using multivariate models. RESULTS: Prevalence of CB was directly associated with smoking habits and inversely associated with high socio-economic status (SES), forced expiratory volume in ¾ sec (FEV) and the ratio FEV/vital capacity (VC). Fifty-year mortality from CB was directly predicted by CB prevalence (from a minimum hazard ratio [HR] 2.35, 95% confidence limits [CI] 1.70-3.24, to a maximum HR 3.01, CI 2.18-5.20, depending on diagnostic criteria and different models) and age, and inversely by high SES, FEV and FEV/VC. The same applied in models predicting mortality from coronary heart disease (HR for prevalent CB: 1.53, CI 1.24-1.88), major cardiovascular diseases (HR 1.43, CI 1.23-1.67) and all-cause mortality (HR 1.48, CI 1.34-1.64) all adjusted for age, high SES, smoking habits and FEV. CONCLUSIONS: CB is strongly associated with major cardiovascular disease and all-cause mortality while FEV and FEV/VC seem to carry at least partly an independent role from CB in predicting long-term mortality.
Subject(s)
Bronchitis, Chronic/epidemiology , Bronchitis, Chronic/mortality , Cardiovascular Diseases/complications , Adult , Bronchitis, Chronic/etiology , Bronchitis, Chronic/physiopathology , Cause of Death , Cohort Studies , Europe/epidemiology , Female , Follow-Up Studies , Forced Expiratory Volume , Forecasting , Humans , Male , Middle Aged , Multivariate Analysis , Prevalence , Smoking/adverse effects , Social Class , Time Factors , Vital CapacityABSTRACT
OBJECTIVES: In the US, chronic bronchitis (CB) is common and is associated with substantial morbidity and mortality. Data on CB in the Hispanic/Latino population-a large, diverse US minority-are scarce. We aimed to test whether the prevalence of CB varies across Hispanic/Latino heritages and to identify CB risk factors, including occupational exposures, in this population. METHODS: We analysed data from the Hispanic Community Health Study/Study of Latinos, a US population-based probability sample of participants aged 18-74 years (n=16 415) including those with Mexican, Puerto Rican, Dominican, Cuban, Central American and South American heritages. Participants who had a completed respiratory questionnaire and valid spirometric data were included in the analysis (n=13 259). CB, place of birth, heritage, occupational exposures and other risk factors were based on standardised questionnaires. The prevalence of CB was estimated using survey logistic regression-conditional marginal analysis. RESULTS: The estimated (mean (95% CI)) overall adjusted prevalence of CB was 12.1% (9.3 to 15.6), with a large variation across heritages. Dominican heritage had a fivefold higher prevalence than South American heritage. US-born participants had a higher adjusted prevalence than their non-US-born counterparts (16.8% (12.5 to 22.1) vs 11.0% (8.5 to 14.10); p=0.022). Compared with non-exposed participants, those exposed to cleaning or disinfecting solutions had a higher adjusted prevalence of CB (12.6% (9.1 to 17.1) vs 11.8% (9.2 to 15.1); p=0.024). CONCLUSIONS: The prevalence of CB was higher among Dominicans than other Hispanic/Latino heritages. CB was more prevalent among US-born participants and those exposed to cleaning and disinfecting solutions.
Subject(s)
Bronchitis, Chronic/epidemiology , Bronchitis, Chronic/etiology , Hispanic or Latino/statistics & numerical data , Occupational Exposure/adverse effects , Residence Characteristics/statistics & numerical data , Adolescent , Adult , Aged , Emigrants and Immigrants , Female , Humans , Latin America/ethnology , Male , Middle Aged , Risk Factors , South America/ethnology , Spirometry , Surveys and Questionnaires , United States/epidemiology , Young AdultABSTRACT
BACKGROUND: Air pollution is a risk factor for chronic obstructive pulmonary disease (COPD). Fraction of exhaled nitric oxide (FeNO) could be a useful biomarker for health effects of air pollutants. However, there were limited data from older populations with higher prevalence of COPD and other inflammatory conditions. METHODS: We obtained data from the German Study on the influence of Air pollution on Lung function, Inflammation and Ageing. Spirometry and FeNO were measured by standard techniques. Air pollutant exposures were estimated following the European Study of Cohorts for Air Pollution Effects protocols, and ozone (O3) measured at the closest ground level monitoring station. Multiple linear regression models were fitted to FeNO with each pollutant separately and adjusted for potential confounders. RESULTS: In 236 women (mean age 74.6 years), geometric mean FeNO was 15.2ppb. Almost a third (n=71, 30.1%) of the women had some chronic inflammatory respiratory condition. A higher FeNO concentration was associated with exposures to fine particles (PM2.5), PM2.5absorbance and respirable particles (PM10). There were no significant associations with PMcoarse, NO2, NOx, O3 or length of major roads within a 1 km buffer. Restricting the analysis to participants with a chronic inflammatory respiratory condition, with or without impaired lung function produced similar findings. Adjusting for diabetes did not materially alter the findings. There were no significant interactions between individual pollutants and asthma or current smoking. CONCLUSIONS: This study adds to the evidence to reduce ambient PM2.5 concentrations as low as possible to protect the health of the general population.
Subject(s)
Air Pollutants/adverse effects , Air Pollution/adverse effects , Asthma/etiology , Bronchitis, Chronic/etiology , Pulmonary Disease, Chronic Obstructive/etiology , Rhinitis, Allergic, Seasonal/etiology , Aged , Air Pollutants/analysis , Air Pollution/analysis , Asthma/epidemiology , Biomarkers/analysis , Bronchitis, Chronic/epidemiology , Cross-Sectional Studies , Environmental Exposure/analysis , Exhalation , Female , Follow-Up Studies , Germany/epidemiology , Humans , Middle Aged , Nitric Oxide/analysis , Ozone/analysis , Particulate Matter/analysis , Pulmonary Disease, Chronic Obstructive/epidemiology , Rhinitis, Allergic, Seasonal/epidemiology , Risk Factors , Spirometry/methodsABSTRACT
INTRODUCTION: Risk of osteoporosis known to increase in chronic obstructive pulmonary disease (COPD), but is usually overlooked, especially in male patients. OBJECTIVES: The present study compares the bone mineral density (BMD) measurements of male COPD patients with emphysema and the chronic bronchitis phenotype, and evaluates the association between density of emphysema and osteoporosis. METHODS: Ninety-four patients with COPD, and with emphysema and the chronic bronchitis phenotype, were included in the prospective study. A high-resolution computed tomography (HRCT) was used for the diagnosis of emphysema, and a dual X-ray absorptiometry was used to measure the BMD of the lumbar vertebrae and neck of the femur. RESULTS: Emphysema phenotype 45.75% and chronic bronchitis phenotype 54.25%, based on their clinical findings and a quantitative volumetric analysis by HRCT. Osteoporosis was found 60.47% and 17.65% of patients with emphysema and bronchitis, while osteopenia was detected 27.91% and 41.18% of patients with emphysema and bronchitis, respectively. A negative correlation was found between HRCT emphysema density and the bone densitometer t-score in patients with osteoporosis. Among the patients with osteoporosis, a positive correlation was found between Body Mass Index (BMI) and the bone densitometer t-score. Only BMI and emphysema score were found to be independent risk factors for a low BMD. One unit drop in BMI increased the risk of osteoporosis by 28% (OR = 1.28, 95% CI 1.14-1.45) (P < 0.001). One unit increase in emphysema score increased the risk of osteoporosis by 6% (OR = 1.06, 95% CI 1.03-1.09) (P < 0.001). CONCLUSION: Especially male patients with emphysema, high dyspnea score, low BMI and frequent exacerbations should be evaluated for osteoporosis.
Subject(s)
Bone Density/physiology , Bronchitis, Chronic/etiology , Pulmonary Disease, Chronic Obstructive/complications , Pulmonary Emphysema/etiology , Absorptiometry, Photon/methods , Aged , Body Mass Index , Bone Diseases, Metabolic/diagnostic imaging , Bone Diseases, Metabolic/epidemiology , Bronchitis, Chronic/diagnostic imaging , Case-Control Studies , Cross-Sectional Studies , Disease Progression , Humans , Inpatients , Lumbar Vertebrae/diagnostic imaging , Male , Middle Aged , Osteoporosis/diagnostic imaging , Osteoporosis/epidemiology , Phenotype , Prospective Studies , Pulmonary Disease, Chronic Obstructive/epidemiology , Pulmonary Disease, Chronic Obstructive/physiopathology , Pulmonary Emphysema/diagnostic imaging , Risk Factors , Tomography, X-Ray Computed/methods , Turkey/epidemiologyABSTRACT
Pulmonary manifestations of inflammatory bowel disease are increasingly recognized in patients with ulcerative colitis and Crohn's disease. Most commonly, incidental abnormalities are noted on chest imaging or pulmonary function tests. Although clinically significant pulmonary disease is less common, it can carry significant morbidity for patients. We review the presenting symptoms, workup, and management for several of the more common forms of inflammatory bowel disease-related pulmonary disease. Increased awareness of the spectrum of extraintestinal inflammatory bowel disease will help providers more readily recognize this phenomenon in their own patients and more comprehensively address the protean sequelae of inflammatory bowel disease.
Subject(s)
Inflammatory Bowel Diseases/complications , Lung Diseases/etiology , Bronchiectasis/etiology , Bronchiectasis/physiopathology , Bronchiolitis/etiology , Bronchiolitis/physiopathology , Bronchitis, Chronic/etiology , Bronchitis, Chronic/physiopathology , Humans , Immunosuppressive Agents/adverse effects , Inflammatory Bowel Diseases/drug therapy , Inflammatory Bowel Diseases/physiopathology , Lung Diseases/physiopathology , Lung Diseases, Interstitial/etiology , Lung Diseases, Interstitial/physiopathology , Pleurisy/etiology , Pleurisy/physiopathology , Pulmonary Eosinophilia/etiology , Pulmonary Eosinophilia/physiopathology , Pulmonary Fibrosis/etiology , Pulmonary Fibrosis/physiopathology , Tracheitis/etiology , Tracheitis/physiopathology , Tumor Necrosis Factor Inhibitors/adverse effectsABSTRACT
Occupational exposures to gas, fumes, dust and chemicals contribute to non-malignant respiratory diseases like asthma, chronic obstructive pulmonary disease, idiopathic pulmonary fibrosis and community-acquired pneumonia in more than one in ten patients. They may be sick due to inhaling various particles, gases, fumes, or chemicals in the workplace. Hence, these exposures should be considered in all patients with non-malignant respiratory diseases. In an international literature review the occupational burden of asthma was 16%, chronic obstructive pulmonary disease 14%, idiopathic pulmonary fibrosis 26% and community-acquired pneumonia 10%.
Subject(s)
Inhalation Exposure/adverse effects , Occupational Exposure/adverse effects , Respiratory Tract Diseases/etiology , Alveolitis, Extrinsic Allergic/etiology , Asthma/etiology , Bronchitis, Chronic/etiology , Humans , Occupational Diseases/etiology , Pneumonia/etiology , Pulmonary Disease, Chronic Obstructive/etiology , Pulmonary Fibrosis/etiology , Sarcoidosis/etiologyABSTRACT
Cigarette smoke is well recognized to cause injury to the airways and the alveolar walls over time. This injury usually requires many years of exposure, suggesting that the lungs may rapidly develop responses that initially protect it from this repetitive injury. Our studies tested the hypotheses that smoke induces an inflammatory response and changes in mRNA profiles that are dependent on sex and the health status of the lung, and that the response of the lungs to smoke differs after 1 day compared to 5 days of exposure. Male and female wildtype (WT) and Scnn1b-transgenic (ßENaC) mice, which have chronic bronchitis and emphysematous changes due to dehydrated mucus, were exposed to cigarette smoke or sham air conditions for 1 or 5 days. The inflammatory response and gene expression profiles were analyzed in lung tissue. Overall, the inflammatory response to cigarette smoke was mild, and changes in mediators were more numerous after 1 than 5 days. ßENaC mice had more airspace leukocytes than WT mice, and smoke exposure resulted in additional significant alterations. Many genes and gene sets responded similarly at 1 and 5 days: genes involved in oxidative stress responses were upregulated while immune response genes were downregulated. However, certain genes and biological processes were regulated differently after 1 compared to 5 days. Extracellular matrix biology genes and gene sets were upregulated after 1 day but downregulated by 5 days of smoke compared to sham exposure. There was no difference in the transcriptional response to smoke between WT and ßENaC mice or between male and female mice at either 1 or 5 days. Taken together, these studies suggest that the lungs rapidly alter gene expression after only one exposure to cigarette smoke, with few additional changes after four additional days of repeated exposure. These changes may contribute to preventing lung damage.
Subject(s)
Bronchitis, Chronic/pathology , Emphysema/pathology , Lung/drug effects , Nicotiana/toxicity , Smoke/adverse effects , Animals , Bronchitis, Chronic/diagnosis , Bronchitis, Chronic/etiology , Bronchoalveolar Lavage Fluid/chemistry , Bronchoalveolar Lavage Fluid/cytology , Disease Models, Animal , Emphysema/diagnosis , Emphysema/etiology , Epithelial Sodium Channels/genetics , Female , Gene Expression Profiling , Gene Expression Regulation/drug effects , Humans , Lung/pathology , Male , Mice , Mice, Inbred C57BL , Mice, Transgenic , Oxidative Stress/drug effects , Sex Factors , Smoking/adverse effects , Time FactorsABSTRACT
OBJECTIVES: Chronic bronchitis (CB) is an important chronic obstructive pulmonary disease (COPD)-related phenotype, with distinct clinical features and prognostic implications. Occupational exposures have been previously associated with increased risk of CB but few studies have examined this association prospectively using objective exposure assessment. We examined the effect of occupational exposures on CB incidence in the European Community Respiratory Health Survey. METHODS: Population samples aged 20-44 were randomly selected in 1991-1993, and followed up twice over 20 years. Participants without chronic cough or phlegm at baseline were analysed. Coded job histories during follow-up were linked to the ALOHA Job Exposure Matrix, generating occupational exposure estimates to 12 categories of chemical agents. Their association with CB incidence over both follow-ups was examined with Poisson models using generalised estimating equations. RESULTS: 8794 participants fulfilled the inclusion criteria, contributing 13 185 observations. Only participants exposed to metals had a higher incidence of CB (relative risk (RR) 1.70, 95% CI 1.16 to 2.50) compared with non-exposed to metals. Mineral dust exposure increased the incidence of chronic phlegm (RR 1.72, 95% CI 1.43 to 2.06). Incidence of chronic phlegm was increased in men exposed to gases/fumes and to solvents and in women exposed to pesticides. CONCLUSIONS: Occupational exposures are associated with chronic phlegm and CB, and the evidence is strongest for metals and mineral dust exposure. The observed differences between men and women warrant further investigation.
Subject(s)
Bronchitis, Chronic/etiology , Incidence , Occupational Exposure/adverse effects , Adult , Australia/epidemiology , Bronchitis, Chronic/complications , Bronchitis, Chronic/epidemiology , Cough/epidemiology , Cough/etiology , Dust , Europe/epidemiology , Female , Gases/adverse effects , Health Surveys , Humans , Longitudinal Studies , Male , Middle Aged , Occupational Exposure/statistics & numerical data , Pesticides/adverse effects , Risk Factors , Smoking/adverse effects , Smoking/epidemiology , United States/epidemiologyABSTRACT
OBJECTIVE: To assess the predictors associated with incidence and longitudinal changes in the prevalence of chronic bronchitis (CB) among farm and non-farm residents of rural Saskatchewan, Canada. METHODS: The Saskatchewan Rural Health Study was a prospective study of the lung health of rural dwellers. We obtained information on 4624 households, 8261 individuals (2797 households, 4867 individuals) at baseline (follow-up). RESULTS: Incidence of CB was 4.3% over 4 years. The prevalence was 6.4% and 5.3% (baseline) and 12.1% and 9.2% (follow-up) in non-farm and farm residents, respectively. The prevalence of CB was associated with current smokers; father ever had lung trouble; obesity; mother smoked during pregnancy; allergic reaction to cats and to pollen; household income inadequacy and age. CONCLUSION: Prevalence and incidence of CB in rural people appear to be a complex mix of personal and contextual factors.
Subject(s)
Agricultural Workers' Diseases/epidemiology , Bronchitis, Chronic/epidemiology , Rural Health/trends , Adolescent , Adult , Aged , Aged, 80 and over , Agricultural Workers' Diseases/etiology , Bronchitis, Chronic/etiology , Female , Health Surveys , Humans , Incidence , Logistic Models , Longitudinal Studies , Male , Middle Aged , Prevalence , Prospective Studies , Risk Factors , Saskatchewan/epidemiology , Young AdultABSTRACT
BACKGROUND: Early life exposure to tobacco smoke has been extensively studied but the role of second-hand smoke (SHS) for new-onset respiratory symptoms and lung function decline in adulthood has not been widely investigated in longitudinal studies. Our aim is to investigate the associations of exposure to SHS in adults with respiratory symptoms, respiratory conditions and lung function over 20 years. METHODS: We used information from 3011 adults from 26 centres in 12 countries who participated in the European Community Respiratory Health Surveys I-III and were never or former smokers at all three surveys. Associations of SHS exposure with respiratory health (asthma symptom score, asthma, chronic bronchitis, COPD) were analysed using generalised linear mixed-effects models adjusted for confounding factors (including sex, age, smoking status, socioeconomic status and allergic sensitisation). Linear mixed-effects models with additional adjustment for height were used to assess the relationships between SHS exposure and lung function levels and decline. RESULTS: Reported exposure to SHS decreased in all 26 study centres over time. The prevalence of SHS exposure was 38.7% at baseline (1990-1994) and 7.1% after the 20-year follow-up (2008-2011). On average 2.4% of the study participants were not exposed at the first, but were exposed at the third examination. An increase in SHS exposure over time was associated with doctor-diagnosed asthma (odds ratio (OR): 2.7; 95% confidence interval (95%-CI): 1.2-5.9), chronic bronchitis (OR: 4.8; 95%-CI: 1.6-15.0), asthma symptom score (count ratio (CR): 1.9; 95%-CI: 1.2-2.9) and dyspnoea (OR: 2.7; 95%-CI: 1.1-6.7) compared to never exposed to SHS. Associations between increase in SHS exposure and incidence of COPD (OR: 2.0; 95%-CI: 0.6-6.0) or lung function (ß: - 49 ml; 95%-CI: -132, 35 for FEV1 and ß: - 62 ml; 95%-CI: -165, 40 for FVC) were not apparent. CONCLUSION: Exposure to second-hand smoke may lead to respiratory symptoms, but this is not accompanied by lung function changes.
Subject(s)
Health Status , Respiratory System/physiopathology , Tobacco Smoke Pollution/adverse effects , Adult , Asthma/epidemiology , Asthma/etiology , Bronchitis, Chronic/epidemiology , Bronchitis, Chronic/etiology , Dyspnea/epidemiology , Dyspnea/etiology , Europe/epidemiology , European Union , Follow-Up Studies , Health Surveys , Humans , Incidence , Prevalence , Respiratory Function Tests , Respiratory Tract Diseases/epidemiology , Respiratory Tract Diseases/etiology , Socioeconomic Factors , Tobacco Smoke Pollution/statistics & numerical dataABSTRACT
OBJECTIVE: To compare the prevalence of chronic obstructive pulmonary disease (COPD) between miners extracting coal versus other minerals. METHODS: The study population was based on New Mexico miners, mostly Hispanic and American Indian, attending a rural community-based mobile screening clinic program between 1989 and 2014. We compared self-reported symptoms, lung diseases, and spirometric patterns between 1353 coal miners and 4140 non-coal miners. RESULTS: Obstruction was the most common abnormal spirometric pattern among all miners (16.9%). Coal miners were more likely to demonstrate an obstructive pattern and report chronic bronchitis symptoms than non-coal miners (adjusted odds ratio [OR]â=â1.24, 95% confidence interval [CI]: 1.03, 1.48; and ORâ=â1.47, 95% CI: 1.24, 1.75, respectively). These associations remained significant among never smoking miners. CONCLUSIONS: The prevention and management of COPD among coal miners deserves greater emphasis by rural health care delivery systems.